NEW YORK (Reuters Health) – An episode of herpes zoster is associated with an increased risk of developing anterior uveitis in the following year, according to the results…
NEW YORK (Reuters Health) – A Japanese team has confirmed endoscopically that when a standard once-daily dose of rabeprazole fails to resolve reflux esophagitis, a twice-daily regimen may…
NEW YORK (Reuters Health) – A multicenter center study has shown that adding cetuximab to neoadjuvant chemotherapy and preoperative radiotherapy improves overall survival after excision of high-risk rectal…
NEW YORK (Reuters Health) – Contrary to previous reports, losartan is not associated with increased mortality risk in patients with heart failure, according the results of a Danish…
NEW YORK (Reuters Health) – A multicenter center study has shown that adding cetuximab to neoadjuvant chemotherapy and preoperative radiotherapy improves overall survival after excision of high-risk rectal…
NEW YORK (Reuters Health) – Among patients with atrial fibrillation undergoing percutaneous coronary intervention, adverse event rates are similar with either drug-eluting stents (DESs) or bare metal stents…
NEW YORK (Reuters Health) – Warming contrast medium from room temperature to body temperature reduces pain experienced during hysterosalpingography and the occurrence of vasovagal episodes, according to the…
NEW YORK (Reuters Health) – Among patients with atrial fibrillation undergoing mechanical valve replacement, performing a concomitant Maze procedure during surgery reduces the rate of subsequent thromboembolic events,…
NEW YORK (Reuters Health) – In general, adding pemetrexed to cisplatin therapy does not improve overall survival (OS) in patients with recurrent or metastatic head and neck cancer,…
NEW YORK (Reuters Health) – Occult Staphylococcus aureus bacteremia is a “rare but important” issue in adult emergency department patients, one that deserves closer attention, a team of…
